Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Phantom Shocks in ICD Patients: State-of-the-art Review
Author(s): Khaled Elenizi , Rasha Alharthi Added: 1 year ago

Electrophysiology & Arrhythmia
When ICDs Do Not Deliver: The Unseen Burden of Untreated Arrhythmias
Author(s): Christopher Monkhouse , Charles D Swerdlow , Robert Hauser , et al Added: 1 month ago

Electrophysiology & Arrhythmia
Job title: Consultant Cardiologist
José M Montero-Cabezas
Job title: Interventional Cardiologist
Dr José Montero-Cabezas is an interventional cardiologist at Leiden University Medical Center (LUMC), Netherlands. He completed his cardiology training at the 12 de Octubre University Hospital (Complutense University, Madrid), followed by a fellowship in interventional cardiology at LUMC. He holds a PhD from Leiden University, a Master’s degree in Healthcare Management and Administration from CEU… View more
Jacob Eifer Møller
Research Area(s) / Expertise:

Heart Failure

Sudden Cardiac Death

 Job title: Cardiologist
Professor Jacob Eifer Møller is a cardiologist at Rigshospitalet, Copenhagen University Hospital, Denmark. His expertise spans acute cardiac care, cardiogenic shock, and advanced mechanical circulatory support. View more
Alexander G Truesdell
Personal History An Army combat veteran, Dr Alexander G Truesdell previously served in infantry, intelligence, medical and special operations units in the United States, Europe, the Balkans, Iraq and Afghanistan.1 He is now an Interventional Cardiologist and Co-Director of the Multidisciplinary Cardiac Shock Team at Inova Heart and Co-Director of Interventional Cardiology Research at… View more
Balimkiz Senman
Dr Balimkiz Senman is a cardiology fellow at Duke University Hospital in Boston, MA, US. Her research interests include cardiogenic shock, mechanical circulatory support, critical care and intervention. View more
Ablation Beats Sotalol for VT in VANISH2 Substudy
Added: 2 months ago Source:  Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events… View more

Electrophysiology & Arrhythmia

MI/ACS
Job title: Clinical Professor, Chief Physician, PhD, Research Director
Prof Jacob Møller is clinical professor at the Odense University Hospital in Denmark. His main research interests include cardiogenic shock, mechanical circulatory support and invasive hemodynamic testing. View more
Ablation vs Drugs for VT: Insights from VANISH2
Added: 2 months ago Source:  Radcliffe Cardiology
A prespecified substudy of the VANISH2 trial suggests first-line catheter ablation is superior to sotalol for reducing arrhythmia events in eligible patients with ischaemic cardiomyopathy and ventricular tachycardia (VT).¹ In patients ineligible for sotalol, ablation showed comparable efficacy to amiodarone but with a markedly better long-term safety profile.MethodologyThe VANISH2 (Ventricular… View more

MI/ACS

Electrophysiology & Arrhythmia